2-hexynyladenosine-5'-n-ethylcarboxamide and 1,3-dipropyl-8-cyclopentylxanthine

2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 2 studies

Compound Research Comparison

Studies (2-hexynyladenosine-5'-n-ethylcarboxamide)	Trials (2-hexynyladenosine-5'-n-ethylcarboxamide)	Recent Studies (post-2010) (2-hexynyladenosine-5'-n-ethylcarboxamide)	Studies (1,3-dipropyl-8-cyclopentylxanthine)	Trials (1,3-dipropyl-8-cyclopentylxanthine)	Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine)
28	0	2	1,301	1	165

Protein Interaction Comparison

Protein	Taxonomy	1,3-dipropyl-8-cyclopentylxanthine (IC50)
Adenosine receptor A1	Rattus norvegicus (Norway rat)	0.0051
Adenosine receptor A3	Rattus norvegicus (Norway rat)	0.0038
Adenosine receptor A2a	Homo sapiens (human)	0.2033
Adenosine receptor A2b	Homo sapiens (human)	0.0234
Adenosine receptor A1	Homo sapiens (human)	0.0083

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C	1
Arslan, G; Fredholm, BB; Kull, B; Lorenzen, A; Nilsson, C; Owman, C; Schwabe, U	1

Other Studies

2 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and 1,3-dipropyl-8-cyclopentylxanthine

Article	Year
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261. British journal of pharmacology, 1997, Volume: 121, Issue:3 Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles	1997
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochemical pharmacology, 1999, Jan-01, Volume: 57, Issue:1 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Kinetics; PC12 Cells; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Triazoles; Tritium	1999

Article

Year

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.

British journal of pharmacology, 1997, Volume: 121, Issue:3

Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles

1997

Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.

Biochemical pharmacology, 1999, Jan-01, Volume: 57, Issue:1

Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Kinetics; PC12 Cells; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Triazoles; Tritium

1999